Log In
Print this Print this

GS 9450 (formerly LB84451)

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionOral, once-daily pan-caspase inhibitor
Molecular Target Caspases
Mechanism of ActionCaspase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsPrevent liver fibrosis in hepatitis C virus (HCV) patients; Treat chronic HCV
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today